Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 MYSM1 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	1.56e-16	124	132	16	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 MYSM1 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	7.90e-16	137	132	16	GO:0019783
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	1.07e-15	114	132	15	GO:0004843
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	2.58e-12	192	132	15	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 CTRB2 USP17L5 USP17L19 MYSM1 USP17L18 USP17L17 USP42 ADAM2 CTRB1 USP17L22 YME1L1 USP17L15 USP17L13	1.14e-08	654	132	20	GO:0008233
GeneOntologyMolecularFunction	5-methylcytosine dioxygenase activity	TET2 TET1	1.30e-04	3	132	2	GO:0070579
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH12 DNAH6 DNAH8	2.14e-04	18	132	3	GO:0008569
GeneOntologyMolecularFunction	calcium ion binding	ANXA6 SMOC1 PKD1L3 DYSF CRB1 FAT1 DST CDH20 MYL6B SYT1 SCIN HSPA5 CDH12 CDH18	4.43e-04	749	132	14	GO:0005509
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH12 DNAH6 DNAH8	8.20e-04	28	132	3	GO:0051959
GeneOntologyMolecularFunction	oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor	STEAP3 MTRR	8.91e-04	7	132	2	GO:0016723
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	2.74e-15	125	132	15	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	2.33e-14	144	132	15	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 DCAF15 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 DYSF USP17L18 USP17L17 USP42 ANKIB1 UBA6 USP17L22 HSPA5 USP17L15 USP17L13	6.50e-06	1009	132	20	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 DCAF15 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 DYSF USP17L18 USP17L17 USP42 ANKIB1 UBA6 USP17L22 HSPA5 USP17L15 USP17L13	1.62e-05	1074	132	20	GO:0043687
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	1.94e-05	8	100	3	MP:0012119
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	2.17e-26	16	128	13	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	2.17e-26	16	128	13	IPR006861
Domain	USP_CS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L13	1.39e-17	66	128	14	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L13	3.40e-17	70	128	14	PS00972
Domain	UCH	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L13	4.21e-17	71	128	14	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L13	4.21e-17	71	128	14	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L13	5.20e-17	72	128	14	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L13	5.20e-17	72	128	14	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L13	5.20e-17	72	128	14	IPR001394
Domain	Tet_JBP	TET2 TET1	4.66e-05	2	128	2	PF12851
Domain	2OGFeDO_noxygenase_dom	TET2 TET1	4.66e-05	2	128	2	IPR024779
Domain	Tet_JBP	TET2 TET1	4.66e-05	2	128	2	SM01333
Domain	Dynein_heavy_chain_D4_dom	DNAH12 DNAH6 DNAH8	1.08e-04	14	128	3	IPR024317
Domain	Dynein_heavy_dom-2	DNAH12 DNAH6 DNAH8	1.08e-04	14	128	3	IPR013602
Domain	DHC_N2	DNAH12 DNAH6 DNAH8	1.08e-04	14	128	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH12 DNAH6 DNAH8	1.08e-04	14	128	3	IPR011704
Domain	AAA_8	DNAH12 DNAH6 DNAH8	1.08e-04	14	128	3	PF12780
Domain	AAA_5	DNAH12 DNAH6 DNAH8	1.08e-04	14	128	3	PF07728
Domain	DHC_fam	DNAH12 DNAH6 DNAH8	1.35e-04	15	128	3	IPR026983
Domain	Dynein_heavy	DNAH12 DNAH6 DNAH8	1.35e-04	15	128	3	PF03028
Domain	Dynein_heavy_dom	DNAH12 DNAH6 DNAH8	1.35e-04	15	128	3	IPR004273
Domain	ECH_1	CDY1 CDYL CDY2A	1.99e-04	17	128	3	PF00378
Domain	Crotonase_core_superfam	CDY1 CDYL CDY2A	1.99e-04	17	128	3	IPR001753
Domain	Gtr1_RagA	RRAGC RRAGD	2.77e-04	4	128	2	IPR006762
Domain	Gtr1_RagA	RRAGC RRAGD	2.77e-04	4	128	2	PF04670
Domain	ARM-type_fold	RELCH SCYL1 RICTOR ECPAS CLHC1 AP2A1 PI4KA DIAPH1 XPOT	5.52e-04	339	128	9	IPR016024
Domain	VWA	COL6A6 COL28A1 COL21A1 VWA5A	5.87e-04	56	128	4	PF00092
Domain	Cadherin_C	CDH20 CDH12 CDH18	6.48e-04	25	128	3	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH20 CDH12 CDH18	6.48e-04	25	128	3	IPR000233
Domain	Laminin_G	LAMA3 CRB1 FAT1 COL21A1	6.71e-04	58	128	4	IPR001791
Domain	Chromo	CDY1 CDYL CDY2A	7.28e-04	26	128	3	PF00385
Domain	CHROMO_1	CDY1 CDYL CDY2A	9.09e-04	28	128	3	PS00598
Domain	CHROMO_2	CDY1 CDYL CDY2A	9.09e-04	28	128	3	PS50013
Domain	Catenin_binding_dom	CDH20 CDH12 CDH18	1.01e-03	29	128	3	IPR027397
Domain	-	CDH20 CDH12 CDH18	1.01e-03	29	128	3	4.10.900.10
Domain	Chromodomain-like	CDY1 CDYL CDY2A	1.35e-03	32	128	3	IPR016197
Domain	Chromo/shadow_dom	CDY1 CDYL CDY2A	1.48e-03	33	128	3	IPR000953
Domain	CHROMO	CDY1 CDYL CDY2A	1.48e-03	33	128	3	SM00298
Domain	-	COL6A6 COL28A1 COL21A1 VWA5A	1.67e-03	74	128	4	3.40.50.410
Domain	STI1	ST13P5 RAD23B	2.02e-03	10	128	2	SM00727
Domain	CUE	SMARCAD1 N4BP2	2.02e-03	10	128	2	IPR003892
Domain	CUE	SMARCAD1 N4BP2	2.02e-03	10	128	2	PS51140
Domain	STI1_HS-bd	ST13P5 RAD23B	2.02e-03	10	128	2	IPR006636
Domain	Chromo_dom_subgr	CDY1 CDY2A	2.02e-03	10	128	2	IPR017984
Domain	LAM_G_DOMAIN	LAMA3 CRB1 FAT1	2.23e-03	38	128	3	PS50025
Domain	VWFA	COL6A6 COL28A1 COL21A1 VWA5A	2.44e-03	82	128	4	PS50234
Domain	Laminin_G_2	LAMA3 CRB1 FAT1	2.58e-03	40	128	3	PF02210
Domain	VWA	COL6A6 COL28A1 COL21A1 VWA5A	2.66e-03	84	128	4	SM00327
Domain	LamG	LAMA3 CRB1 FAT1	3.39e-03	44	128	3	SM00282
Domain	Dynein_HC_stalk	DNAH6 DNAH8	4.02e-03	14	128	2	IPR024743
Domain	MT	DNAH6 DNAH8	4.02e-03	14	128	2	PF12777
Domain	-	LAMA3 CRB1 FAT1 COL21A1	4.14e-03	95	128	4	2.60.120.200
Domain	-	RELCH SCYL1 RICTOR ECPAS AP2A1 XPOT	4.30e-03	222	128	6	1.25.10.10
Domain	FH2	GRID2IP DIAPH1	4.62e-03	15	128	2	PS51444
Domain	FH2_Formin	GRID2IP DIAPH1	4.62e-03	15	128	2	IPR015425
Domain	FH2	GRID2IP DIAPH1	4.62e-03	15	128	2	PF02181
Domain	FH2	GRID2IP DIAPH1	4.62e-03	15	128	2	SM00498
Domain	VWF_A	COL6A6 COL28A1 COL21A1 VWA5A	4.80e-03	99	128	4	IPR002035
Domain	-	APBB1 ALS2 ARHGEF16 MTMR10 OPHN1 SNTG1 PLEKHM3 EPB41L2	5.56e-03	391	128	8	2.30.29.30
Domain	-	FMO1 PYROXD2 RETSAT	6.69e-03	56	128	3	3.50.50.60
Domain	Cadherin_CS	FAT1 CDH20 CDH12 CDH18	6.73e-03	109	128	4	IPR020894
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	6.05e-18	45	105	13	MM15671
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 CCP110 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 MYSM1 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13 RAD23B	8.53e-12	262	105	17	MM15286
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 CCP110 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	1.05e-11	191	105	15	MM15289
Pathway	REACTOME_DEUBIQUITINATION	CCP110 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 MYSM1 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13 RAD23B	6.90e-11	299	105	17	M27574
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	CCP110 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	8.45e-11	221	105	15	M27578
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 PAK1 USP17L22 USP17L15 USP17L13	9.60e-08	318	105	14	MM15278
Pathway	REACTOME_SMOOTH_MUSCLE_CONTRACTION	ANXA6 DYSF MYL6B PAK1	2.87e-04	43	105	4	M1429
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.49e-27	21	134	13	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.49e-27	21	134	13	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.49e-27	21	134	13	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.49e-27	21	134	13	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.49e-27	21	134	13	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.49e-27	21	134	13	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.09e-26	22	134	13	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	5.46e-26	24	134	13	8995226
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	6.07e-26	33	134	14	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.03e-25	34	134	14	21448158
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.13e-25	25	134	13	21115691
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.71e-25	35	134	14	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.71e-25	35	134	14	21239494
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.26e-25	26	134	13	35816173
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.79e-25	36	134	14	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-25	37	134	14	20228808
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.46e-24	29	134	13	32527007
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	7.13e-21	50	134	13	31806660
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 TET2 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 MORC2 OPHN1 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	8.13e-09	674	134	16	37196079
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 OPHN1 USP17L18 USP17L17	2.15e-08	119	134	8	28625976
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	2.23e-07	4	134	3	22984479
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	COL6A6 CDK11A HMMR MORC2 ECPAS PARVG DYSF SNX14 DNAH12 GRID2IP UBA6 XPOT	5.54e-07	497	134	12	36774506
Pubmed	Retroposition of autosomal mRNA yielded testis-specific gene family on human Y chromosome.	CDY1 CDYL CDY2A	5.56e-07	5	134	3	10192397
Pubmed	TET-Mediated Sequestration of miR-26 Drives EZH2 Expression and Gastric Carcinogenesis.	TET2 EZH2 TET1	5.56e-07	5	134	3	28923852
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	ZFYVE16 APBB1 RETSAT DMXL1 RRAGC SNX14 DST PI4KA STEAP3 PLEKHM3 SCIN YME1L1	6.42e-07	504	134	12	34432599
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PDCD2 ELP1 RICTOR SMARCAD1 PFKP EFTUD2 DST AP2A1 WDR75 TFB1M PI4KA MKI67 DIAPH1 ANKIB1 YME1L1 CPSF3 HSPA5 EPB41L2 XPOT	1.14e-06	1353	134	19	29467282
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	HEXA ZFYVE16 SMARCAD1 PFKP RETSAT BPTF FAT1 DST AP2A1 WDR75 MKI67 DIAPH1 CDYL ST13P5 CPSF3 HSPA5 EPB41L2 XPOT	2.65e-06	1297	134	18	33545068
Pubmed	Mammalian chromodomain proteins: their role in genome organisation and expression.	CDY1 CDYL CDY2A	3.09e-06	8	134	3	10655032
Pubmed	Previously uncharacterized histone acetyltransferases implicated in mammalian spermatogenesis.	CDY1 CDYL CDY2A	3.09e-06	8	134	3	12072557
Pubmed	TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons.	TET2 EZH2 TET1	4.62e-06	9	134	3	31361780
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	USP17L7 USP17L12 COL28A1 PFKP ECPAS PARVG DST CDH20 GALNT11 PI4KA HSPA5 DSE EPB41L2	5.82e-06	736	134	13	29676528
Pubmed	Tagging genes with cassette-exchange sites.	RELCH SMARCAD1 EZH2 DYSF DMXL1 BPTF TET1 MKI67 XPOT	6.51e-06	335	134	9	15741177
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L2 USP17L15	6.58e-06	10	134	3	24207026
Pubmed	The TIP60 Complex Is a Conserved Coactivator of HIF1A.	ELP1 RICTOR ECPAS EFTUD2 FAT1 XPOT	7.45e-06	120	134	6	27320910
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	FRAS1 ORC3 ELP1 RICTOR SMARCAD1 HMMR MORC2 EZH2 DST TRMT2A CDK13 ANKIB1	8.71e-06	650	134	12	38777146
Pubmed	Postmitotic Hoxa5 Expression Specifies Pontine Neuron Positional Identity and Input Connectivity of Cortical Afferent Subsets.	CHL1 EZH2 NRP2 MKI67	8.93e-06	34	134	4	32553152
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	PDCD2 FRAS1 SCYL1 ELP1 HMMR ECPAS USP17L18 AP2A1 TFB1M CPSF3 HSPA5 XPOT	9.11e-06	653	134	12	33742100
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CDK11A RICTOR SMARCAD1 PFKP MORC2 ECPAS EZH2 EFTUD2 BPTF USP42 CDK13 MKI67 EPB41L2	9.94e-06	774	134	13	15302935
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ANXA6 ELP1 PFKP EFTUD2 BPTF DST AP2A1 WDR75 PI4KA MYL6B MKI67 UBA6 SCIN HSPA5 EPB41L2	1.02e-05	1024	134	15	24711643
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SCYL1 APBB1 RICTOR DMXL1 CRB1 EFTUD2 FAT1 DST TENM3 PI4KA MKI67 STEAP3 EPB41L2	1.04e-05	777	134	13	35844135
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ORC3 ELP1 ECPAS EFTUD2 TRMT2A AP2A1 WDR75 DIAPH1 HSPA5 EPB41L2 XPOT	1.18e-05	560	134	11	35241646
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L2 USP17L15	1.20e-05	12	134	3	24695638
Pubmed	Comparative analysis of type II classic cadherin mRNA distribution patterns in the developing and adult mouse somatosensory cortex and hippocampus suggests significant functional redundancy.	CDH20 CDH12 CDH18	1.20e-05	12	134	3	22102170
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ALS2 DYSF MTMR10 EFTUD2 BPTF DST RRAGD POLK XPOT	1.24e-05	363	134	9	14691545
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	HEXA RELCH ANXA6 SPC25 SCYL1 ELP1 SMARCAD1 SMOC1 PFKP ECPAS EFTUD2 DIAPH1 UBA6 MTRR HSPA5 EPB41L2 XPOT RAD23B	1.28e-05	1455	134	18	22863883
Pubmed	Distributive Processing by the Iron(II)/α-Ketoglutarate-Dependent Catalytic Domains of the TET Enzymes Is Consistent with Epigenetic Roles for Oxidized 5-Methylcytosine Bases.	TET2 TET1	1.47e-05	2	134	2	27362828
Pubmed	Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.	TET2 TET1	1.47e-05	2	134	2	30045709
Pubmed	Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells.	TET2 TET1	1.47e-05	2	134	2	23415914
Pubmed	The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.	CTRB2 CTRB1	1.47e-05	2	134	2	28951524
Pubmed	Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.	CTRB2 CTRB1	1.47e-05	2	134	2	28754779
Pubmed	Ten-Eleven Translocation Proteins Modulate the Response to Environmental Stress in Mice.	TET2 TET1	1.47e-05	2	134	2	30540950
Pubmed	Tet1 Deficiency Leads to Premature Reproductive Aging by Reducing Spermatogonia Stem Cells and Germ Cell Differentiation.	TET2 TET1	1.47e-05	2	134	2	32114381
Pubmed	Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.	TET2 TET1	1.47e-05	2	134	2	35955629
Pubmed	Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.	TET2 TET1	1.47e-05	2	134	2	24474761
Pubmed	Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA.	CTRB2 CTRB1	1.47e-05	2	134	2	2917002
Pubmed	Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.	TET2 TET1	1.47e-05	2	134	2	30606231
Pubmed	Genomic cloning and partial characterization of human chymotrypsinogen gene.	CTRB2 CTRB1	1.47e-05	2	134	2	8186414
Pubmed	Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways.	TET2 TET1	1.47e-05	2	134	2	34165552
Pubmed	Ezh2 regulates the Lin28/let-7 pathway to restrict activation of fetal gene signature in adult hematopoietic stem cells.	TET2 EZH2	1.47e-05	2	134	2	26773568
Pubmed	Tet-mediated imprinting erasure in H19 locus following reprogramming of spermatogonial stem cells to induced pluripotent stem cells.	TET2 TET1	1.47e-05	2	134	2	26328763
Pubmed	EZH2 is highly expressed in pituitary adenomas and associated with proliferation.	EZH2 MKI67	1.47e-05	2	134	2	26593398
Pubmed	Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma.	LAMA3 DST	1.47e-05	2	134	2	24675808
Pubmed	Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance.	TET2 EZH2	1.47e-05	2	134	2	21339759
Pubmed	Structural insight into substrate preference for TET-mediated oxidation.	TET2 TET1	1.47e-05	2	134	2	26524525
Pubmed	Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation.	ANXA6 EZH2	1.47e-05	2	134	2	25947258
Pubmed	Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice.	CTRB2 CTRB1	1.47e-05	2	134	2	30076839
Pubmed	Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.	EZH2 MKI67	1.47e-05	2	134	2	19773751
Pubmed	Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis.	CTRB2 CTRB1	1.47e-05	2	134	2	33036922
Pubmed	Evolutionary relationships between laboratory mice and subspecies of Mus musculus based on the restriction fragment length variants of the chymotrypsin gene at the Prt-2 locus.	CTRB2 CTRB1	1.47e-05	2	134	2	2565717
Pubmed	Redox-active quinones induces genome-wide DNA methylation changes by an iron-mediated and Tet-dependent mechanism.	TET2 TET1	1.47e-05	2	134	2	24214992
Pubmed	Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.	EZH2 TET1	1.47e-05	2	134	2	30809307
Pubmed	PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis.	MORC2 PAK1	1.47e-05	2	134	2	25888627
Pubmed	Ten-eleven translocation protein 1 modulates medulloblastoma progression.	TET2 TET1	1.47e-05	2	134	2	33926529
Pubmed	Reciprocal regulation of endothelial-mesenchymal transition by MAPK7 and EZH2 in intimal hyperplasia and coronary artery disease.	EZH2 MAPK7	1.47e-05	2	134	2	34493753
Pubmed	Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogramming.	TET2 TET1	1.47e-05	2	134	2	24672749
Pubmed	A primary role of TET proteins in establishment and maintenance of De Novo bivalency at CpG islands.	TET2 TET1	1.47e-05	2	134	2	27288448
Pubmed	Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation.	TET2 TET1	1.47e-05	2	134	2	26598602
Pubmed	Coordinated regulation of dendrite arborization by epigenetic factors CDYL and EZH2.	EZH2 CDYL	1.47e-05	2	134	2	24671995
Pubmed	Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.	TET2 TET1	1.47e-05	2	134	2	26586431
Pubmed	Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.	TET2 TET1	1.47e-05	2	134	2	35075236
Pubmed	Ten-Eleven Translocation 1 and 2 Confer Overlapping Transcriptional Programs for the Proliferation of Cultured Adult Neural Stem Cells.	TET2 TET1	1.47e-05	2	134	2	27778125
Pubmed	TET-dependent regulation of retrotransposable elements in mouse embryonic stem cells.	TET2 TET1	1.47e-05	2	134	2	27863519
Pubmed	Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism.	TET2 TET1	1.47e-05	2	134	2	28783731
Pubmed	Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.	TET2 TET1	1.47e-05	2	134	2	28252217
Pubmed	MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response.	MORC2 PAK1	1.47e-05	2	134	2	23260667
Pubmed	Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice.	CTRB2 SI SLC2A5 CTRB1	1.91e-05	41	134	4	23676500
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	PDCD2 ELP1 RRAGC DST TFB1M MKI67 YME1L1	1.93e-05	212	134	7	33853758
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH12 DNAH6 DNAH8	1.97e-05	14	134	3	9373155
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L2 USP17L15	1.97e-05	14	134	3	11793228
Interaction	FLT3 interactions	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 ECPAS OPHN1 USP17L18 USP17L17 PI4KA XPOT	7.50e-06	318	131	11	int:FLT3
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	9.13e-18	79	133	12	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.78e-12	222	133	12	chr4p16
Cytoband	16q23.1	NUDT7 CTRB2 CTRB1	1.11e-04	32	133	3	16q23.1
Cytoband	5p14.3	CDH12 CDH18	1.73e-04	7	133	2	5p14.3
Cytoband	18q21.33	RELCH CDH20	9.73e-04	16	133	2	18q21.33
GeneFamily	CD molecules\|Type II classical cadherins	CDH20 CDH12 CDH18	2.14e-05	13	78	3	1186
GeneFamily	Dyneins, axonemal	DNAH12 DNAH6 DNAH8	5.03e-05	17	78	3	536
GeneFamily	Collagens	COL6A6 COL28A1 COL21A1	1.03e-03	46	78	3	490
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.67e-16	86	132	13	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.63e-14	112	132	13	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.72e-12	160	132	13	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 SPC25 USP17L5 ALS2 USP17L19 USP17L18 USP17L17 POLK USP17L22 USP17L15 USP17L13	1.76e-07	647	132	16	MM981
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 ANXA6 USP17L5 ALS2 USP17L19 EZH2 RETSAT USP17L18 USP17L17 PAK1 STEAP3 USP17L22 SLC16A7 USP17L15 USP17L13	2.40e-06	1198	132	20	MM1062
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 SPC25 USP17L5 SMARCAD1 USP17L19 RETSAT RRAGC USP17L18 USP17L17 GTF2IRD2 POLK USP17L22 SCIN USP17L15 USP17L13	3.40e-06	1226	132	20	MM979
Coexpression	JOHNSTONE_PARVB_TARGETS_1_DN	DMXL1 FAT1 UBA6 SLC16A7 DSE	1.80e-05	64	132	5	M2237
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 USP17L21 PDCD2 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 ECPAS USP17L18 USP17L17 USP17L22 ST13P5 USP17L15 EPB41L2 USP17L13	2.83e-05	1072	132	17	MM1031
Coexpression	ODONNELL_TFRC_TARGETS_DN	SPC25 APBB1 HMMR ACVR2B BPTF MKI67	7.56e-05	139	132	6	M6451
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 SMOC1 DST ATP6V0A4 DIAPH1 CDYL SCIN SLC16A7	6.60e-08	188	126	8	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 SMOC1 DST ATP6V0A4 DIAPH1 CDYL SLC16A7	1.03e-06	186	126	7	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CHL1 COL28A1 DST TENM3 COL21A1 EPB41L2	8.43e-06	168	126	6	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	NS-critical-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SMOC1 ARHGEF16 DST SLC14A1 ATP6V0A4 SCIN	8.43e-06	168	126	6	6a233045638cb83dab64789b996b7598c325001e
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPC25 HMMR SMOC1 EZH2 MKI67 PAK1	9.02e-06	170	126	6	badbe200e9d5003d23d115955b10b4ea767f6c26
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HEXA ZFP90 SPC25 HMMR SLC46A3 STEAP3	9.96e-06	173	126	6	12c6875f881cb0fbff09d753b53c1cce7a95527f
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A6 SPC25 HMMR SMOC1 TENM3 MKI67	1.13e-05	177	126	6	4197cf2b1e743230c821f422836fa5991b155a52
ToppCell	NS-moderate-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FMO1 DST SLC14A1 RASSF6 ATP6V0A4 SCIN	1.13e-05	177	126	6	99500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPC25 HMMR EZH2 DYSF NRP2 MKI67	1.13e-05	177	126	6	73ba0f0b4b33f10e9f036d6d9befa48a1258e682
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 COL6A6 SPC25 CRB1 DST CTRB1	1.17e-05	178	126	6	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	NS-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SMOC1 ARHGEF16 DST SLC14A1 ATP6V0A4 SCIN	1.21e-05	179	126	6	65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c
ToppCell	NS-critical-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FMO1 SMOC1 DST TENM3 SLC14A1 RASSF6	1.37e-05	183	126	6	ba43bca2b45be1008eebd3f033cecb061fb3a966
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMOC1 PFKP SLC14A1 RASSF6 ATP6V0A4 SCIN	1.41e-05	184	126	6	a60802e11dcc5f932811260b08a95a32f60f6b19
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMOC1 PFKP SLC14A1 RASSF6 ATP6V0A4 SCIN	1.41e-05	184	126	6	39c230d32e4259bc784e0edfd9e2884c96898564
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMOC1 PFKP SLC14A1 RASSF6 ATP6V0A4 SCIN	1.41e-05	184	126	6	2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2
ToppCell	critical-Epithelial-Ionocyte\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FMO1 SMOC1 DST SLC14A1 RASSF6 ATP6V0A4	1.41e-05	184	126	6	58d36577eff814d46d72f031f3533d71549e3d6e
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL28A1 DST TENM3 COL21A1 EPB41L2	1.46e-05	185	126	6	f607b6ee579562e2f92103fa5c7053df0170a229
ToppCell	5'-Adult-LargeIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL28A1 DST TENM3 COL21A1 EPB41L2	1.46e-05	185	126	6	317f2c854f00aa5957319b818c85eeed7d72ec7f
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL28A1 DST TENM3 COL21A1 EPB41L2	1.46e-05	185	126	6	7bb8fdfe04f85d25056380ec58222366de323a21
ToppCell	COVID_vent-Myeloid-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SI DST PAK1 STEAP3 DSE EPB41L2	1.50e-05	186	126	6	63a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell	COVID_vent-Myeloid-Dendritic-cDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SI DST PAK1 STEAP3 DSE EPB41L2	1.50e-05	186	126	6	39457a7b43537f2c3e221f9375c95d4515424d7d
ToppCell	moderate-Epithelial-Ionocyte\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FMO1 SMOC1 DST SLC14A1 RASSF6 ATP6V0A4	1.55e-05	187	126	6	3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	CHL1 OPHN1 FAT1 SLC14A1 SCIN EPB41L2	1.60e-05	188	126	6	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA3 CDH20 RASSF6 SNTG1 EPB41L2 CDH18	1.70e-05	190	126	6	1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31
ToppCell	Myeloid-Myeloid-B_(Activated_Macrophage)\|Myeloid / shred on cell class and cell subclass (v4)	HEXA RRAGC NRP2 DST HSPA5 EPB41L2	1.75e-05	191	126	6	7bf125249af1e8bb138ed4d999fdd74b03ab2447
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA3 SI SLC2A5 RASSF6 SCIN CDH12	1.80e-05	192	126	6	4a2c82e7af700ae6f04742027877768b151f5d81
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	FRAS1 COL6A6 NRP2 DST TENM3 COL21A1	1.80e-05	192	126	6	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	BLOOD--(1)_Activated_T_cells\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ORC3 SPC25 HMMR EZH2 MYL6B MKI67	1.96e-05	195	126	6	45515d5da8a8c8242eb70a1bea24fe44eca5407b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 HMMR ARHGEF16 GRID2IP RASSF6 MKI67	1.96e-05	195	126	6	5812b1615676f3b77eb4769216b98b360c417c0d
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A6 DST TENM3 COL21A1 EPB41L2	2.08e-05	197	126	6	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	proximal-Epithelial-Ionocyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SMOC1 PFKP RASSF6 ATP6V0A4 SCIN CDH12	2.08e-05	197	126	6	f65c35761da7c168d5c6e4d7edf5dafa26652fe4
ToppCell	proximal-Epithelial-Ionocyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SMOC1 PFKP RASSF6 ATP6V0A4 SCIN CDH12	2.08e-05	197	126	6	e5d5accefaacea5ed2e22f906f5bcbc75083f287
ToppCell	proximal-3-Epithelial-Ionocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SMOC1 PFKP RASSF6 ATP6V0A4 SCIN CDH12	2.08e-05	197	126	6	288492fc67d8e81349d38e82caf1f1890276b299
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CHL1 COL28A1 DST TENM3 COL21A1 EPB41L2	2.08e-05	197	126	6	b2f4d7c301c0b24003374923b31d6d058e40b213
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SMOC1 PKD1L3 DYSF NRP2 SYT1 EPB41L2	2.14e-05	198	126	6	b3a020522e064bb61949d38e442f24026e339364
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SMOC1 PKD1L3 DYSF NRP2 SYT1 EPB41L2	2.14e-05	198	126	6	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A6 ANXA6 DST TENM3 COL21A1	2.20e-05	199	126	6	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 LAMA3 ARHGEF16 FAT1 DST RASSF6	2.20e-05	199	126	6	c88a28a73f54dc571f2ff1e4b55073f83cbead2c
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 LAMA3 ARHGEF16 FAT1 DST RASSF6	2.26e-05	200	126	6	9da214f756a03516eaafde00289b90f69623b9f3
ToppCell	VE-CD4-CD8_2\|VE / Condition, Cell_class and T cell subcluster	ANKRD30B CRB1 LRRC9 DNAH12 CDH20	2.54e-05	122	126	5	6745035feaf807b6a6b9537ac9d5ee0e000196eb
ToppCell	COVID-19-kidney-Mito-rich_Int\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SNTG1 CTRB1 TBC1D21 CDH12 CDH18	2.54e-05	122	126	5	a4220adb4e6055a599bd9bbf65d460fc4e68b543
ToppCell	COVID-19-Fibroblasts-Mesothelial_FB\|COVID-19 / group, cell type (main and fine annotations)	FRAS1 PTPRQ SNTG1 CDH12 CDH18	5.07e-05	141	126	5	7e6dcccb74e7ee90b69dc91b59491b84f3a713c9
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 CRB1 PTPRQ ADAM2 ATP12A	5.79e-05	145	126	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SNTG1 SYT1 DNAH8 CDH12 CDH18	6.38e-05	148	126	5	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	ZFYVE16 RICTOR CCDC168 ACVR2B CDYL	6.59e-05	149	126	5	768877bade04ca0321593b8470b5011ad8270431
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SI SNTG1 DNAH8 CDH12 CDH18	6.80e-05	150	126	5	0205318a870e091add66ee4305747dda9f51510d
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LAMA3 ARHGEF16 RASSF6 ATP6V0A4 CDH12	7.94e-05	155	126	5	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LAMA3 ARHGEF16 GRID2IP RASSF6 ATP12A	8.69e-05	158	126	5	98712ed7e8e65e8c5ff9318cf0e0a04e271a055d
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	SNTG1 SYT1 DNAH8 CDH12 CDH18	8.96e-05	159	126	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCAF15 MKI67 EXOC6B PAK1 CDH18	9.50e-05	161	126	5	a7e74bc80ac11250e353e5614b19c05793fc2e95
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 PTPRQ ADAM2 ATP12A CDH12	9.78e-05	162	126	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	11.5-Distal-RBC\|Distal / Age, Tissue, Lineage and Cell class	HMMR SLC14A1 STEAP3 CDYL PLEKHM3	1.01e-04	163	126	5	e9d814952d824539ff1dea119e4fca14a8c335a8
ToppCell	11.5-Distal-RBC-RBC\|Distal / Age, Tissue, Lineage and Cell class	HMMR SLC14A1 STEAP3 CDYL PLEKHM3	1.01e-04	163	126	5	31b60e065bac4ad380247964e7574f210106ebae
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NUDT7 ANKRD30B HMMR MKI67 ATP12A	1.04e-04	164	126	5	1642a67c66eeb77a218e7814e3cfe517d9822955
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HMMR PKD1L3 RASSF6 MKI67 SYT1	1.04e-04	164	126	5	b92e7c91910d518627376166c6ea9ed333b3d07e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NUDT7 ANKRD30B HMMR MKI67 ATP12A	1.04e-04	164	126	5	25758fb8112baf296264122d5d4121f1ebb3d0fa
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HMMR PKD1L3 RASSF6 MKI67 SYT1	1.04e-04	164	126	5	a1e43c6b3e2553f5604100db6e92bf244b70c36d
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCP110 NUDT7 AP2A1 GTF2IRD2 POLK	1.07e-04	165	126	5	7c771f22b58989572c939ed127e637ec28dc0dca
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	CHL1 COL28A1 TENM3 COL21A1 EPB41L2	1.07e-04	165	126	5	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	facs-Spleen-nan-24m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPC25 HMMR ACVR2B MKI67 PAK1	1.13e-04	167	126	5	16bb7293fc8ca582b7cb4450917aff07b34fc70a
ToppCell	facs-Spleen-nan-24m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPC25 HMMR ACVR2B MKI67 PAK1	1.13e-04	167	126	5	515988c7035c550a2f072430d9d7027869593d17
ToppCell	droplet-Lung-LUNG-1m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPC25 SMOC1 EZH2 PAK1 SCIN	1.13e-04	167	126	5	e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671
ToppCell	facs-Spleen-nan-24m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPC25 HMMR ACVR2B MKI67 PAK1	1.13e-04	167	126	5	f12d00e6c600b0bba3e4e1b1c80b791e095de931
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL28A1 CRB1 DST TENM3	1.16e-04	168	126	5	948d9e9972bd2a4b503d55fa69b70dd568a35a67
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPC25 HMMR C18orf21 MKI67 PAK1	1.19e-04	169	126	5	a1efc20e34a81ae32f8d278a5486811ade03ef24
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA3 LRRC9 ATP6V0A4 ADAM2 SCIN	1.19e-04	169	126	5	4b3a7b4a497178799b6b2f0b744f5fb752cee31a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA3 LRRC9 ATP6V0A4 ADAM2 SCIN	1.19e-04	169	126	5	a4fd646b9bf87225131fca530bd6b52df9eaf489
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HEXA SPC25 HMMR PFKP STEAP3	1.23e-04	170	126	5	7534ac69ca3a378df78d61c284e89bc96a71a4a8
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SI DST PAK1 STEAP3 EPB41L2	1.23e-04	170	126	5	7bba77ae34a0259fad6ee98cf665ff50f77a1328
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SI DST PAK1 STEAP3 EPB41L2	1.23e-04	170	126	5	a43b977a7fe745536cf96b7c080397d9fa73086b
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_12\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DST MKI67 PAK1 STEAP3 EPB41L2	1.33e-04	173	126	5	a55f310c533432e9e26e400026a5b47245152976
ToppCell	BL-critical-LOC-Lymphoid-PC\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPC25 HMMR SLC2A5 RASSF6 DNAH8	1.33e-04	173	126	5	90700a876d997f7c0f7b3899dffcda7fdafee547
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPC25 SMOC1 EZH2 SLC46A3 PAK1	1.33e-04	173	126	5	15af4a0f7516dbf5c93ba66a19aca073ebe30d04
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_12\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DST MKI67 PAK1 STEAP3 EPB41L2	1.33e-04	173	126	5	9c7386bf0a899882c733f0b4921a96afde032a7d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPC25 HMMR EZH2 PARVG MKI67	1.37e-04	174	126	5	7b318796728001c17b4043d2b033330c7be40c78
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPC25 HMMR ACVR2B EZH2 MKI67	1.37e-04	174	126	5	72df66319f6efbd88ecf439013d97409fbf3cb52
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPC25 HMMR ACVR2B EZH2 MKI67	1.37e-04	174	126	5	c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	FMO1 CLHC1 FAT1 DNAH12 PLEKHM3	1.37e-04	174	126	5	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPC25 HMMR EZH2 MKI67 PAK1	1.40e-04	175	126	5	a6913f992a1ea20b43e5adeca3ede3a6fda820ad
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPC25 CCDC168 HMMR EZH2 MKI67	1.40e-04	175	126	5	d43ae33a6256606ce848247cad32d74f21b38988
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 FMO1 DYSF LRRC9 TENM3	1.44e-04	176	126	5	27e5115fae5f0f63b333bc99fbf6a6d4c9182c46
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SPC25 HMMR ACVR2B DNAH12 MKI67	1.44e-04	176	126	5	8813c01ea080f373fe3970c5e1ba4c2dca0f7f02
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NRP2 LRRC9 ATP6V0A4 SCIN CDH12	1.44e-04	176	126	5	6c7edf1cb38644500bce6c5a1dd90bbe17415cdb
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPC25 HMMR RRAGD TENM3 MKI67	1.48e-04	177	126	5	3e149bff1f1b393a7abe98984e37981c8296f95d
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 COL6A6 DST COL21A1 PTPRQ	1.48e-04	177	126	5	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	NS-moderate-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPC25 HMMR EZH2 PTPRQ MKI67	1.48e-04	177	126	5	174c54acfe19e2bb31418d69e228032ba724cbb6
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 COL6A6 DST COL21A1 PTPRQ	1.48e-04	177	126	5	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPC25 HMMR EZH2 RRAGD MKI67	1.48e-04	177	126	5	3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMOC1 PKD1L3 NRP2 DST EPB41L2	1.52e-04	178	126	5	ad3de3e03a401dac64431a541899445262246347
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPC25 LAMA3 HMMR EZH2 MKI67	1.56e-04	179	126	5	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDH20 RASSF6 ATP12A TBC1D21 DNAH6	1.56e-04	179	126	5	53e700494d251ec5649b2dea5fc7d5aeeeed572b
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	SPC25 HMMR ACVR2B DNAH12 MKI67	1.56e-04	179	126	5	e67ad7ab04d0c1309296f57c1f53c5ca14c213fe
ToppCell	NS-moderate-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FMO1 SMOC1 DST SLC14A1 ATP6V0A4	1.60e-04	180	126	5	8af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCell	5'-Adult-SmallIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL28A1 TENM3 COL21A1 EPB41L2	1.60e-04	180	126	5	5e6e38ee0758ef2342a6a821c78ed24b57bb7b11
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA3 SLC2A5 RASSF6 SCIN CDH12	1.60e-04	180	126	5	d1beaf1f106c7efaeaf61f29742d0a7310a83916
ToppCell	390C-Fibroblasts-Fibroblast-G\|390C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 COL6A6 DST TENM3 COL21A1	1.60e-04	180	126	5	137fc14859c89e1ecd98bee388bb58c04b835847
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA3 CDH20 SNTG1 CDH12 CDH18	1.60e-04	180	126	5	5391d23817f5cc88a0871ddb98968897c839f464
ToppCell	5'-Adult-SmallIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL28A1 TENM3 COL21A1 EPB41L2	1.60e-04	180	126	5	b88cd7ae922782176c057342d1b9eb9b8e5e7204
ToppCell	5'-Adult-SmallIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL28A1 TENM3 COL21A1 EPB41L2	1.60e-04	180	126	5	ebd6e719a03f25155fa8181be19469d04d6d10a6
ToppCell	RA-16._Neuronal\|RA / Chamber and Cluster_Paper	CHL1 COL28A1 TENM3 COL21A1 EPB41L2	1.60e-04	180	126	5	5842febfdabac61ce970254fb0ef17a628f1b8c0
Drug	BOCPheONP	CTRB2 CTRB1	2.80e-05	2	121	2	CID000111308
Drug	MPM-06	CTRB2 CTRB1	2.80e-05	2	121	2	CID000161546
Drug	NSC-374899	CTRB2 CTRB1	2.80e-05	2	121	2	CID000435726
Drug	methylbenzenebutanoate	CTRB2 CTRB1	2.80e-05	2	121	2	CID000281254
Drug	Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu	CTRB2 CTRB1	2.80e-05	2	121	2	CID004418081
Drug	c189	CTRB2 CTRB1	2.80e-05	2	121	2	CID000248048
Drug	dansyl-D-arginine methyl ester	CTRB2 CTRB1	2.80e-05	2	121	2	CID000191369
Drug	methyl 6-phenylhexanoate	CTRB2 CTRB1	2.80e-05	2	121	2	CID011820300
Drug	5-aminotetrazole	CTRB2 CTRB1	2.80e-05	2	121	2	CID000020467
Drug	2-bromoisobutyric acid	CTRB2 CTRB1	2.80e-05	2	121	2	CID000074924
Drug	p-toluamidine	CTRB2 CTRB1	2.80e-05	2	121	2	CID000122753
Drug	N-acetyl-alpha-azaphenylalanine phenyl ester	CTRB2 CTRB1	2.80e-05	2	121	2	CID000191275
Drug	isobutyl sulfide	CTRB2 CTRB1	2.80e-05	2	121	2	CID000011607
Drug	Pd-Ti	CTRB2 TET1 CTRB1	4.03e-05	13	121	3	CID006452040
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	PDCD2 ECPAS SLC2A5 GALNT11 STEAP3 SLC16A7 XPOT	7.15e-05	190	121	7	1612_DN
Drug	ptaquiloside	FAT1 DST TFB1M MKI67 SYT1 ADAM2	7.87e-05	133	121	6	ctd:C043680
Drug	N-acetylbenzotriazole	CTRB2 CTRB1	8.37e-05	3	121	2	CID000087784
Drug	photophor	CTRB2 CTRB1	8.37e-05	3	121	2	CID000014780
Drug	dibutyl iodomethaneboronate	CTRB2 CTRB1	8.37e-05	3	121	2	CID000098591
Drug	zinc;dipicolinate	CTRB2 CTRB1	8.37e-05	3	121	2	CID004309911
Drug	2-oxobut-3-ynoate	CTRB2 CTRB1	8.37e-05	3	121	2	CID000171547
Drug	AFMeq	CTRB2 CTRB1	8.37e-05	3	121	2	CID000194069
Drug	Bz-Cti-otbu	CTRB2 CTRB1	8.37e-05	3	121	2	CID006452691
Drug	n-(2-oxoethyl)benzamide	CTRB2 CTRB1	8.37e-05	3	121	2	CID000188995
Drug	AC1L49DM	CTRB2 CTRB1	8.37e-05	3	121	2	CID000152933
Drug	c140	CTRB2 CTRB1	8.37e-05	3	121	2	CID002783250
Drug	Benzamidomethaneboronic acid	CTRB2 CTRB1	8.37e-05	3	121	2	CID000127677
Drug	phenyl hippurate	CTRB2 CTRB1	8.37e-05	3	121	2	CID000076323
Drug	FK-386	CTRB2 CTRB1	8.37e-05	3	121	2	CID000135044
Drug	FK-375	CTRB2 CTRB1	8.37e-05	3	121	2	CID000135042
Drug	carbostyril-124	CTRB2 CTRB1	8.37e-05	3	121	2	CID000088277
Drug	N-trifluoroacetyl-4-fluorophenylalanine	CTRB2 CTRB1	8.37e-05	3	121	2	CID000328214
Drug	C18 4	CTRB2 CTRB1	8.37e-05	3	121	2	CID000077248
Drug	taraxastane	CTRB2 CTRB1	8.37e-05	3	121	2	CID006429404
Drug	Phe-phe-ome	CTRB2 CTRB1	8.37e-05	3	121	2	CID000151728
Drug	phenylethaneboronic acid	CTRB2 CTRB1	8.37e-05	3	121	2	CID000065389
Drug	3-amino-2-pyridone	CTRB2 CTRB1	8.37e-05	3	121	2	CID000322353
Drug	ASA-BMPA	CTRB2 CTRB1	8.37e-05	3	121	2	CID003035649
Drug	p-nitrophenyl benzoate	CTRB2 CTRB1	8.37e-05	3	121	2	CID000070396
Drug	Z-Phe-OMe	CTRB2 CTRB1	8.37e-05	3	121	2	CID003082435
Drug	3-methylcoumarin	CTRB2 CTRB1	8.37e-05	3	121	2	CID000017130
Drug	2-propyl methylphosphonochloridate	CTRB2 CTRB1	8.37e-05	3	121	2	CID000102124
Drug	FK-316	CTRB2 CTRB1	8.37e-05	3	121	2	CID000133688
Drug	5-Methylcytosine	TET2 TET1	8.37e-05	3	121	2	ctd:D044503
Drug	AC1L19T8	CTRB2 CTRB1	8.37e-05	3	121	2	CID000000694
Drug	Marinostatin D	CTRB2 CTRB1	8.37e-05	3	121	2	CID000132206
Drug	1FD7	CTRB2 CTRB1	8.37e-05	3	121	2	CID000445579
Drug	Glt-leu-phe-nh-meq	CTRB2 CTRB1	8.37e-05	3	121	2	CID000194914
Drug	AC1L4Z4F	CTRB2 CTRB1	8.37e-05	3	121	2	CID000194913
Drug	Glt-Phe-NH-FMeq	CTRB2 CTRB1	8.37e-05	3	121	2	CID000194912
Drug	diacetyl trimer	CTRB2 CTRB1	8.37e-05	3	121	2	CID000193527
Drug	FK-448	CTRB2 CTRB1	8.37e-05	3	121	2	CID006917869
Drug	Ac-Phe-OMe	CTRB2 CTRB1	8.37e-05	3	121	2	CID000097805
Drug	thiobenzyl N-heptafluorobutyrylanthranilate	CTRB2 CTRB1	8.37e-05	3	121	2	CID000133906
Drug	Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A	TRMT2A TENM3 MTRR SYT1 MAPK7 EPB41L2 RAD23B	8.69e-05	196	121	7	6653_DN
Drug	Benzoyl-dl-leucine	CTRB2 CTRB1	1.67e-04	4	121	2	CID000294887
Drug	Acafcek	CTRB2 CTRB1	1.67e-04	4	121	2	CID000197677
Drug	B-1,3-od	CTRB2 CTRB1	1.67e-04	4	121	2	CID011971053
Drug	dehydromerodesmosine	CTRB2 CTRB1	1.67e-04	4	121	2	CID006443540
Drug	alpha-amyrin palmitate	CTRB2 CTRB1	1.67e-04	4	121	2	CID000185477
Drug	poly-THIQ	CTRB2 CTRB1	1.67e-04	4	121	2	CID006453487
Drug	N-(4-carboxycyclohexylmethyl)-maleimide	CTRB2 CTRB1	1.67e-04	4	121	2	CID011548799
Drug	G2505_sigma	CTRB2 CTRB1	1.67e-04	4	121	2	CID000111098
Drug	p-fluorobenzenesulfonyl chloride	CTRB2 CTRB1	1.67e-04	4	121	2	CID000009588
Drug	BSSDA	CTRB2 CTRB1	1.67e-04	4	121	2	CID003081106
Drug	AC1L2HV6	CTRB2 CTRB1	1.67e-04	4	121	2	CID000047328
Drug	AC1L4X1Z	CTRB2 CTRB1	1.67e-04	4	121	2	CID000193815
Drug	NSC-676827	CTRB2 CTRB1	1.67e-04	4	121	2	CID000385555
Drug	6-amino-1,2-benzopyrone	CTRB2 CTRB1	1.67e-04	4	121	2	CID000046152
Drug	nitrophenylethanol	CTRB2 CTRB1	1.67e-04	4	121	2	CID000097851
Drug	Asp-pro	PDCD2 CTRB2 AP2A1 SYT1 CTRB1	2.36e-04	104	121	5	CID000170612
Drug	Ac-Trp-OEt	CTRB2 CTRB1	2.77e-04	5	121	2	CID000304749
Drug	hydroxyachillin	HEXA PDCD2	2.77e-04	5	121	2	CID000099114
Drug	apne	CTRB2 CTRB1	2.77e-04	5	121	2	CID000098192
Drug	7-chloro-4-nitrobenzofuran	CTRB2 CTRB1	2.77e-04	5	121	2	CID000130782
Drug	DnHP	DST POLK	2.77e-04	5	121	2	CID000019284
Drug	5-hydroxymethylcytosine	TET2 TET1	2.77e-04	5	121	2	ctd:C011865
Drug	Z-Phe-Leu	CTRB2 CTRB1	2.77e-04	5	121	2	CID000333351
Drug	5'-FSBAzA	CTRB2 CTRB1	2.77e-04	5	121	2	CID000130430
Drug	AC1L3F57	CTRB2 CTRB1	2.77e-04	5	121	2	CID000139565
Drug	3,5-dimethylpyrazole-1-carboxamidine	CTRB2 CTRB1	2.77e-04	5	121	2	CID000097525
Drug	Maap-borov	CTRB2 CTRB1	2.77e-04	5	121	2	CID005486914
Drug	2-amino-4,6-dichlorotriazine	CTRB2 CTRB1	2.77e-04	5	121	2	CID000013615
Drug	AC1O52A0	CTRB2 CTRB1	2.77e-04	5	121	2	CID006475891
Drug	allysine aldol	CTRB2 CTRB1	2.77e-04	5	121	2	CID000191270
Drug	Clorgyline	ZFYVE16 RICTOR EZH2 DMXL1 DST POLK	2.82e-04	168	121	6	ctd:D003010
Drug	o-iodosobenzoic acid	CTRB2 SLC14A1 MTRR CTRB1	3.13e-04	61	121	4	CID000067537
Drug	ethanolamine-O-sulfate	CTRB2 ELP1 CDK13 CTRB1	3.13e-04	61	121	4	CID000070223
Drug	Proscillaridin A [466-06-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	PDCD2 SPC25 ELP1 MORC2 ARHGEF16 TFB1M	3.30e-04	173	121	6	7340_DN
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	1.02e-24	46	131	15	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP42 USP17L22 USP17L15 USP17L13	1.04e-21	69	131	15	DOID:1682 (implicated_via_orthology)
Disease	level of chymotrypsinogen B2 in blood serum	CTRB2 CTRB1	1.96e-05	2	131	2	OBA_2041192
Disease	chymotrypsinogen B measurement	CTRB2 CTRB1	5.85e-05	3	131	2	EFO_0801477
Disease	chronic myelomonocytic leukemia (is_implicated_in)	TET2 EZH2	1.94e-04	5	131	2	DOID:0080188 (is_implicated_in)
Disease	follicular lymphoma (implicated_via_orthology)	RRAGC RRAGD	1.94e-04	5	131	2	DOID:0050873 (implicated_via_orthology)
Disease	lung small cell carcinoma (is_implicated_in)	LAMA3 RICTOR FAT1	2.58e-04	28	131	3	DOID:5409 (is_implicated_in)
Disease	Primary Myelofibrosis	TET2 EZH2	2.90e-04	6	131	2	C0001815
Disease	Leukemia, Myelomonocytic, Chronic	TET2 EZH2	2.90e-04	6	131	2	C0023480
Disease	myelodysplastic syndrome (is_implicated_in)	TET2 EZH2 MTRR	3.18e-04	30	131	3	DOID:0050908 (is_implicated_in)
Disease	esophagus squamous cell carcinoma (is_marker_for)	TET2 RICTOR EZH2 FAT1	3.36e-04	74	131	4	DOID:3748 (is_marker_for)
Disease	diffuse large B-cell lymphoma (is_marker_for)	EZH2 MKI67	5.38e-04	8	131	2	DOID:0050745 (is_marker_for)
Disease	trypsin-2 measurement	CTRB2 CTRB1	1.05e-03	11	131	2	EFO_0008305
Disease	Ashkenazi Jewish disorders	HEXA ELP1	1.05e-03	11	131	2	cv:CN118946
Disease	esophagus squamous cell carcinoma (is_implicated_in)	TET2 RICTOR FAT1	1.06e-03	45	131	3	DOID:3748 (is_implicated_in)
Disease	hepatocellular carcinoma (is_implicated_in)	TET2 EZH2 EFTUD2 CDK13 MTRR	1.31e-03	181	131	5	DOID:684 (is_implicated_in)
Disease	Lymphoma, Large-Cell, Follicular	EZH2 RRAGC	1.98e-03	15	131	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	EZH2 RRAGC	1.98e-03	15	131	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	EZH2 RRAGC	1.98e-03	15	131	2	C0079758
Disease	Lymphoma, Follicular, Grade 2	EZH2 RRAGC	1.98e-03	15	131	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	EZH2 RRAGC	1.98e-03	15	131	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	EZH2 RRAGC	1.98e-03	15	131	2	C1956130
Disease	focal segmental glomerulosclerosis	DNAH6 CDH12	2.25e-03	16	131	2	EFO_0004236
Disease	Spermatogenic Failure, Nonobstructive, Y-Linked	CDY1 CDY2A	2.25e-03	16	131	2	C1839071
Disease	SPERMATOGENIC FAILURE, Y-LINKED, 2	CDY1 CDY2A	2.25e-03	16	131	2	415000
Disease	Spermatogenic failure, Y-linked, 2	CDY1 CDY2A	2.25e-03	16	131	2	cv:C1839071
Disease	hepatocellular carcinoma (is_marker_for)	TET2 ANXA6 RICTOR EZH2 EFTUD2 TET1	2.31e-03	301	131	6	DOID:684 (is_marker_for)
Disease	Lymphoma, Follicular	EZH2 RRAGC	3.53e-03	20	131	2	C0024301
Disease	metabolite measurement	FMO1 PYROXD2 SPC25 SMOC1 BPTF SLC34A1 SYT1 RAD23B	3.62e-03	560	131	8	EFO_0004725
Disease	stomach cancer (is_marker_for)	TET2 RICTOR EZH2 MKI67	3.76e-03	142	131	4	DOID:10534 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
QQQDVKSLEFTVEPK	C2orf16	56	Q68DN1
VFKNPKFSILTVNND	CTRB2	106	Q6GPI1
NFVNTFIQFKKPIVV	CDY1	371	Q9Y6F8
KNFVNTFIQFKKPIV	CDY2A	371	Q9Y6F7
TVPNKAFELKNEQTL	ANKRD30B	541	Q9BXX2
DKIRKQININNPFVF	CPSF3	291	Q9UKF6
FTPSDKLKVIQQTFE	ALS2	1566	Q96Q42
KLQSVEPQQDFAKYI	ADAM2	166	Q99965
LPQVEITKAFFAKQA	ARHGEF16	631	Q5VV41
IKFINLFPETKATIQ	AP2A1	546	O95782
QFDIKAFVENNPAIK	ANKIB1	406	Q9P2G1
EFPAPKNELVQKFQV	APBB1	531	O00213
LFKLQFSEQVENIKP	DIAPH1	941	O60610
PVENKIKVLQFLVDQ	BPTF	356	Q12830
QFSPLNEVLKNDVKF	DMXL1	3011	Q9Y485
ELFTKKPIFQANQEL	CDK13	906	Q14004
VAIVQSVKNKPLFFA	ANXA6	591	P08133
SVFVKLQKPNAAIQD	ST13P5	156	Q8NFI4
KTLQQQTFKIDIDPE	RAD23B	6	P54727
PEKVNAVKEAIVNFV	PARVG	206	Q9HBI0
LQKFKIENSPQDFAL	RASSF6	251	Q6ZTQ3
QEVQESKKFNIVEPV	OPHN1	186	O60890
FNNVILEESKKNPEV	LRRC9	636	Q6ZRR7
KIFTNTKVKPQFQEI	RELCH	871	Q9P260
VIVKILDENDNKPQF	FAT1	1231	Q14517
VAIKKIPNAFDVVTN	MAPK7	81	Q13164
FQFLVKDSKPNVVSD	FRAS1	2531	Q86XX4
NFKKTFNLNTTEVEP	LAMA3	2576	Q16787
TIIKQSKVQVAFPFD	CHL1	36	O00533
LPNIQEVQAAFVKLK	MTMR10	336	Q9NXD2
PSAEFKVVKAQIQEQ	DST	5421	Q03001
KVAEIPFNSTNKFQL	ATP12A	491	P54707
KFVKEIQNQTLPVDF	MTRR	71	Q9UBK8
FQFAPTQTKELEEKV	EPB41L2	361	O43491
FQEFSNIVIPLIKKN	ECPAS	1651	Q5VYK3
IFIKDPVQKNEFISE	EZH2	626	Q15910
FQKFKTQIALEPEQI	PDCD2	241	Q16342
NVIFQPVAELKKQTD	PFKP	726	Q01813
SVQEDLVQVQPKFKS	DNAH8	1181	Q96JB1
VLEPQFKANKIDDVI	GALNT11	66	Q8NCW6
QKIVLNFNPHFEIEK	NRP2	66	O60462
NLQPVKFFLEKIIQT	DNAH12	1506	Q6ZR08
DFFNKITNVSAIIKP	PI4KA	1736	P42356
FPKAVTVFFKEIQQI	SLC16A7	36	O60669
AVPDIFAQIEVNEKK	DSE	821	Q9UL01
TQDKPNQQDIVFFEK	ELP1	256	O95163
EFKQFTEQQPAFKVL	LRRC8E	6	Q6NSJ5
KKVVGQFPFQDIELE	EXOC6B	466	Q9Y2D4
DEKNINTFVETPVQK	MKI67	2396	P46013
FIILEKKPTFEVQFN	NUDT7	201	P0C024
KKPTFEVQFNLNDVL	NUDT7	206	P0C024
LETKAQNVFPAKEQF	PLEKHM3	81	Q6ZWE6
IFQVKDIPYFQTKNI	RICTOR	1436	Q6R327
KEPKELNFVFGVNIE	MORC2	361	Q9Y6X9
TFQKIPDEVTKFQLT	PTPRQ	1691	Q9UMZ3
VAKVIQKVINTDFPA	SLC34A1	381	Q06495
KPFQLQLDAFEVEKQ	HMMR	591	O75330
EQKKNPQAVLDVLEF	PAK1	116	Q13153
LTNPKEVKLVFFQDA	DNAH6	2411	Q9C0G6
QPTAKEQVFAALKQF	GRID2IP	151	A4D2P6
VIGVVKKNDPNFEIF	COL28A1	931	Q2UY09
VNTFIQFKKPIIVAV	CDYL	431	Q9Y232
FIIKIQDINDNEPKF	CDH20	151	Q9HBT6
PSIKEVKENSVIFNN	FMO1	301	Q01740
VNITKNFDIGPKFIQ	COL21A1	61	Q96P44
FPGNSEIDQINKVFK	CDK11A	626	Q9UQ88
FKVIPTFVTENNVIK	CCP110	341	O43303
IIKVQDINDNAPKFT	CDH18	146	Q13634
FIIKVQDINDNEPKF	CDH12	146	P55289
KILFVTKQDVPQQLQ	CCDC168	1856	Q8NDH2
FINKPQEEQFLKIST	CRB1	1116	P82279
NYIPKIAELQTEFQK	GTF2IRD2	821	Q86UP8
PSVQQDIKFLPFKVV	HSPA5	106	P11021
IQQLVKEFFNGKEPS	HSPA5	371	P11021
IFEAFSKVVQKLIPQ	RRAGD	226	Q9NQL2
NKKNLVDPFVEVSFA	DYSF	411	O75923
PEQKKEIVTQFTTQF	PRAMEF26	156	H0Y7S4
QNESQKIPKVDFRNF	C18orf21	196	Q32NC0
VFKNPKFSILTVNND	CTRB1	106	P17538
FQPAFQLKKDQVVLL	DCAF15	231	Q66K64
KEISFQIENIKQIFG	COL6A6	1061	A6NMZ7
TQFPFKINEKVLQVL	ORC3	296	Q9UBD5
VFDNKVKIQPDTIIQ	HEXA	376	P06865
KQAFSANQVPEKLDV	RETSAT	56	Q6NUM9
KTLNPVFNEQFTFKV	SYT1	201	P21579
IPEATKQVVKAFQEF	TRMT2A	281	Q8IZ69
FEAFSKVVQKLIPQL	RRAGC	226	Q9HB90
VLKLQKEFPNFDKQE	SMARCAD1	256	Q9H4L7
ELIQKDVPQTLKDFF	TBC1D21	321	Q8IYX1
EIQIKEPAEKQKFFQ	SCYL1	281	Q96KG9
VTEKVAQIKQIPFDA	SCIN	361	Q9Y6U3
KFLFQNPDTKQIEAK	SNTG1	451	Q9NSN8
PETKAKTFIEINQIF	SLC2A5	461	P22732
SPIFAFQEEVQKKVS	SLC46A3	56	Q7Z3Q1
LQNIFISQPVKVVFF	PKD1L3	1196	Q7Z443
PFKLVEKVVQNVFQF	TFB1M	241	Q8WVM0
EQAVQKVFPNKRSFI	SI	571	P14410
GEKLQFIFTNIDPKN	SPC25	151	Q9HBM1
LPAETNVSFKKFNIE	TET1	766	Q8NFU7
TQVPKKKLFQVESQF	ANKRD20A12P	136	Q8NF67
NDFVAVKIFPLQDKQ	ACVR2B	211	Q13705
PFQDFVEQIQKTKYL	CLHC1	256	Q8NHS4
KIQEFKPSNKVVQTD	UBA6	791	A0AVT1
QALEQAKKPQEAVFV	SMOC1	101	Q9H4F8
AAQSVNKALEQFVKP	USP42	266	Q9H9J4
PVDLSKVVIEFNKDQ	MYL6B	51	P14649
QESQNKFFKLPVSVV	STEAP3	241	Q658P3
QELFPELNKVQKEVT	SNX14	926	Q9Y5W7
KQIAQFSQKDAQVFP	PYROXD2	146	Q8N2H3
FVIVNKEKPDIFQLV	WDR75	116	Q8IWA0
QEQNKTKPEFNVRKV	USP17L18	441	D6R9N7
FIQELRKDKFNPVNQ	POLK	806	Q9UBT6
QEQNKTKPEFNVRKV	USP17L5	441	A8MUK1
QEQNKTKPEFNVRKV	USP17L21	441	D6R901
QEQNKTKPEFNVRKV	USP17L13	441	C9JLJ4
DQPQFLKFNISLQKD	TENM3	411	Q9P273
QEQNKTKPEFNVRKV	USP17L19	441	D6RCP7
TAFIAINKELNKPVQ	VWA5A	586	O00534
ANQLKDKPVVLQFID	SLC14A1	46	Q13336
PKVAKQVFQVAAELL	UNQ6494/PRO21346	116	Q6UXR6
LQEVVEFLKNPQKFT	YME1L1	351	Q96TA2
QEQNKTKPEFNVRKV	USP17L12	441	C9JPN9
PVTKEEIQKNIFIIF	ATP6V0A4	211	Q9HBG4
QEQNKTKPEFNVRKV	USP17L24	441	Q0WX57
INQITAKFKIQVSPF	XPOT	746	O43592
QEQNKTKPEFNVRKV	USP17L7	441	P0C7H9
NVKFKILDAVVAQEP	EFTUD2	786	Q15029
QEQNKTKPEFNVRKV	USP17L22	441	D6RA61
FQKPEQLQQQKSVFE	TET2	316	Q6N021
QEQNKTKPEFNVRKV	USP17L15	441	C9J2P7
QEQNKTKPEFNVRKV	USP17L17	441	D6RBQ6
QEQNKTKPEFNVRKV	USP17L2	441	Q6R6M4
QEQNKTKPEFNVRKV	USP17L20	441	D6RJB6
LPDFSFQEDKTVIKQ	ZFYVE16	326	Q7Z3T8
KKIITPQENFEQNKF	ZFP90	146	Q8TF47
QEQNKTKPEFNVRKV	USP17L11	441	C9JVI0
PKVFNINTKSDVQEA	N4BP2	1051	Q86UW6
EKQLFKIFPAINQNF	N4BP2	1526	Q86UW6
KQEPFQVKVASEALL	MYSM1	571	Q5VVJ2